查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1480365

全球癌症诊断市场：到 2033 年的机会和策略

Cancer Diagnostics Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 313 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018年全球癌症诊断市场价值为167.7881亿美元，到2023年复合年增长率将超过4.0%。

对个人化医疗的需求不断增加

对个人化医疗的需求不断增长推动了癌症诊断市场的成长。个人化医疗，也称为精准医疗或个人化医疗，是一种医疗方法，旨在提供适合每个患者特征的治疗和介入措施。个人化医疗透过利用基因组分析、标靶治疗、预测生物标记、精密成像、临床决策支援和药物开发的创新来增强癌症诊断。例如，2022 年 10 月，代表科学家、患者和医疗保健提供者的美国组织个人化医疗联盟促进了对个人化医疗的理解和采用，以造福患者和医疗保健系统。产品和超过300种个人化药物，适用于多种癌症、罕见遗传疾病以及各种慢性和感染疾病患者。因此，对个人化医疗日益增长的需求正在支持癌症诊断市场的成长。

目录

第一章执行摘要

  • 癌症诊断 - 市场吸引力和宏观经济状况

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章市场特征

  • 一般市场定义
  • 概述
  • 癌症诊断市场定义和细分
  • 市场区隔：依方法
    • 切片检查
    • 内视镜检查
    • 肿瘤生物标记检测
    • 影像
    • 其他方法
  • 市场区隔：按应用
    • 子宫颈癌
    • 乳癌
    • 肺癌
    • 脑部和中枢神经系统癌症
    • 肾癌
    • 大肠直肠癌
    • 摄护腺癌
    • 卵巢癌
    • 胃癌
    • 其他用途
  • 市场区隔：按最终用户
    • 癌症研究所
    • 诊断实验室
    • 医院
    • 其他最终用户

第七章癌症诊断市场：宏观经济情景

  • COVID-19 的影响：癌症诊断市场
  • 乌克兰战争的影响：癌症诊断市场
  • 高通膨的影响：癌症诊断市场

第八章 主要市场趋势

  • 技术进步提供自动化诊断解决方案
  • 策略联盟和收购推动癌症诊断创新
  • 开发用于癌症检测的血液循环生物标记
  • 专注于基于人工智慧的癌症诊断工具

第九章世界市场规模与成长

  • 市场规模
  • 2018-2023 年市场成长表现
    • 2018-2023年市场驱动因素
    • 2018-2023年市场限制因素
  • 市场成长预测，2023-2028，2033F
    • 2023-2028年市场驱动因素
    • 2023-2028年市场限制因素

第十章全球癌症诊断市场：细分

  • 全球癌症诊断市场：依方法分類的表现与预测，2018-2023、2028F、2033F
  • 全球癌症诊断市场：按应用分類的表现和预测，2018-2023、2028F、2033F
  • 全球癌症诊断市场：最终用户的表现和预测，2018-2023、2028F、2033F

第十一章癌症诊断市场：区域/国家分析

  • 全球癌症诊断市场：按地区分類的表现和预测，2018-2023、2028F、2033F
  • 全球癌症诊断市场：按国家分類的表现和预测，2018-2023、2028F、2033F

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • 公司简介
  • Thermo Fisher Scientific Inc.
  • F. Hoffman-La Roche Ltd
  • Abbott Laboratories
  • Illumina Inc.
  • Hologic Inc

第20章竞争对手仪表板

第二十一章 重大併购

  • Quest Diagnostics Acquired Haystack Oncology Inc.
  • Agilent Technologies Inc. Acquired Biomed Inc.
  • Thermo Fisher Scientific Inc. Acquired The Binding Site Group
  • Hologic Inc. Acquired Biotheranostics Inc.
  • Illumina Inc. Acquired GRAIL

第22章机会与策略

  • 2028 年全球癌症诊断市场：提供新机会的国家
  • 2028 年全球癌症诊断市场：提供新机会的细分市场
  • 2028 年全球癌症诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第23章癌症诊断市场：结论与建议

  • 结论
  • 推荐
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第24章附录

简介目录
Product Code: o&s1165

Cancer diagnosis refers to the process of identifying and determining the presence, type, extent and characteristics of cancer in a patient. This involves a variety of diagnostic techniques and tools aimed at detecting cancer, determining its stage and grade and guiding treatment decisions.

The cancer diagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of cancer diagnostics technologies and methods that detect substances that may indicate the presence of cancer in the body.

The global cancer diagnostics market was valued at $16,778.81 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 4.0%.

Increase In Demand For Personalized Medicine

An increase in demand for personalized medicine propelled the growth of the cancer diagnostics market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Personalized medicine enhances cancer diagnostics by leveraging genomic profiling, targeted therapies, predictive biomarkers, precision imaging, clinical decision support and innovation in drug development. For instance, in October 2022, according to the Personalized Medicine Coalition's (US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system) estimates, more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Therefore, the increase in demand for personalized medicine supported the growth of the cancer diagnostics market.

Focus On AI-Based Tools In Cancer Diagnosis

Major companies in the cancer diagnostics market are focusing on developing AI-based tools by leveraging machine learning algorithms and big data analytics to improve accuracy, speed, and efficiency. For instance, in April 2023, Google Health, a UK-based platform that provides applications and technologies for healthcare and medical research, offering AI and machine vision technology for various health-related purposes, including skin condition and breast cancer research assistance, was actively involved in developing AI tools for cancer detection and diagnosis, leveraging machine learning algorithms to analyze medical images and improve diagnostic accuracy., Further, in July 2023, IBM, a US-based medical technology company, leveraged artificial intelligence (AI) to aid in cancer diagnostics by analyzing extensive data to offer insights for personalized treatment strategies. The use of AI in healthcare, particularly in cancer diagnosis, holds promise for enhancing patient care and treatment outcomes, but it also underscores the importance of thorough evaluation and refinement to ensure the accuracy and effectiveness of AI-driven tools in clinical settings.

The global cancer diagnostics market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up 13.16% of the total market in 2022.

Cancer Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cancer diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for cancer diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cancer diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cancer diagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by method, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the cancer diagnostics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by method, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for cancer diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Method: Biopsy, Endoscopy; Tumor Biomarker Tests; Imaging; Other Methods
  • 2) By Application: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach Cancer; Other Applications
  • 3) By End User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc; F. Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Illumina Inc.; Hologic Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cancer diagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Cancer Diagnostics - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Cancer Diagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Method
    • 6.4.1 Biopsy
    • 6.4.2 Endoscopy
    • 6.4.3 Tumor Biomarker Tests
    • 6.4.4 Imaging
    • 6.4.5 Other Methods
  • 6.5 Market Segmentation By Application
    • 6.5.1 Cervical Cancer
    • 6.5.2 Breast Cancer
    • 6.5.3 Lung Cancer
    • 6.5.4 Brain And Central Nervous System Cancer
    • 6.5.5 Kidney Cancer
    • 6.5.6 Colorectal Cancer
    • 6.5.7 Prostate Cancer
    • 6.5.8 Ovarian Cancer
    • 6.5.9 Stomach Cancer
    • 6.5.10 Other Applications
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Cancer Research Institutes
    • 6.6.2 Diagnostic Laboratories
    • 6.6.3 Hospitals
    • 6.6.4 Other End-Users

7 Cancer Diagnostics Market - Macro Economic Scenario

  • 7.1 COVID-19 Impact On The Cancer Diagnostics Market
  • 7.2 Impact Of The War In Ukraine On The Cancer Diagnostics Market
  • 7.3 Impact Of High Inflation On The Cancer Diagnostics Market

8 Major Market Trends

  • 8.1 Technological Advancements To Provide Automated Diagnostics Solutions
  • 8.2 Strategic Partnerships And Acquisitions To Drive Innovation In Cancer Diagnostics
  • 8.3 Developments In Blood-Borne Circulating Biomarkers For Cancer Detection
  • 8.4 Focus On AI-Based Tools In Cancer Diagnosis

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Cancer Diagnostics Market Segmentation

  • 10.1 Global Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Cancer Diagnostics Market, Regional and Country Analysis

  • 11.1 Global Cancer Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Cancer Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.2 62
    • 12.1.3 62
    • 12.1.4 62
    • 12.1.5 Background Information
    • 12.1.6 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Cancer Diagnostics Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.1.13 Country Information
    • 12.1.14 Market Information
    • 12.1.15 Background Information
  • 12.8 75
  • 12.9 75
    • 12.9.1 75
    • 12.9.2 75
    • 12.9.3 75
    • 12.9.4 Government Initiatives
    • 12.1.16 Regulations
    • 12.1.17 Regulatory Bodies
    • 12.1.18 Major Associations
    • 12.1.19 Taxes Levied
    • 12.1.20 Corporate Tax Structure
    • 12.1.21 Investments
    • 12.1.22 Major Companies
  • 12.1 China Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Cancer Diagnostics Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Cancer Diagnostics Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Cancer Diagnostics Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Cancer Diagnostics Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Thermo Fisher Scientific Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 F. Hoffman-La Roche Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Abbott Laboratories
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Illumina Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Hologic Inc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Dashboard

21 Key Mergers And Acquisitions

  • 21.1 Quest Diagnostics Acquired Haystack Oncology Inc.
  • 21.2 Agilent Technologies Inc. Acquired Biomed Inc.
  • 21.3 Thermo Fisher Scientific Inc. Acquired The Binding Site Group
  • 21.4 Hologic Inc. Acquired Biotheranostics Inc.
  • 21.5 Illumina Inc. Acquired GRAIL

22 Opportunities And Strategies

  • 22.1 Global Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 22.2 Global Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 22.3 Global Cancer Diagnostics Market In 2028 - Growth Strategies
    • 22.3.1 Market Trend Based Strategies
    • 22.3.2 Competitor Strategies

23 Cancer Diagnostics Market, Conclusions And Recommendations

  • 23.1 Conclusions
  • 23.2 Recommendations
    • 23.2.1 Product
    • 23.2.2 Place
    • 23.2.3 Price
    • 23.2.4 Promotion
    • 23.2.5 People

24 Appendix

  • 24.1 Geographies Covered
  • 24.2 Market Data Sources
  • 24.3 Research Methodology
  • 24.4 Currencies
  • 24.5 The Business Research Company
  • 24.6 Copyright and Disclaimer